Nora Aknay

678 total citations
8 papers, 507 citations indexed

About

Nora Aknay is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Nora Aknay has authored 8 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 1 paper in Pulmonary and Respiratory Medicine and 1 paper in Hematology. Recurrent topics in Nora Aknay's work include Heart Failure Treatment and Management (7 papers), Cardiac pacing and defibrillation studies (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Nora Aknay is often cited by papers focused on Heart Failure Treatment and Management (7 papers), Cardiac pacing and defibrillation studies (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Nora Aknay collaborates with scholars based in United States, Italy and Australia. Nora Aknay's co-authors include Robert Glazer, Jay N. Cohn, Allen Hester, Inder S. Anand, Roberto Latini, Aldo P. Maggioni, Simona Barlera, Maylene Wong, Lidia Staszewsky and Thomas S. Rector and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Nora Aknay

8 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nora Aknay United States	5	397	157	56	55	47	8	507
C Tritto Italy	7	255 0.6×	101 0.6×	79 1.4×	30 0.5×	24 0.5×	12	346
Yee Weng Wong Australia	9	231 0.6×	112 0.7×	54 1.0×	41 0.7×	24 0.5×	33	345
Carles Díez‐López Spain	11	383 1.0×	86 0.5×	22 0.4×	70 1.3×	39 0.8×	37	503
Sudipta Chattopadhyay United Kingdom	10	410 1.0×	80 0.5×	30 0.5×	129 2.3×	91 1.9×	23	566
Yi-Da Tang United States	5	209 0.5×	250 1.6×	20 0.4×	39 0.7×	15 0.3×	7	409
Joseph J. Cuthbert United Kingdom	9	192 0.5×	112 0.7×	114 2.0×	31 0.6×	27 0.6×	23	350
George P. Alexopoulos Greece	9	398 1.0×	274 1.7×	59 1.1×	42 0.8×	11 0.2×	16	609
Deborah Wesley-Farrington United States	7	280 0.7×	53 0.3×	22 0.4×	30 0.5×	17 0.4×	7	329
Lwin Tin United Kingdom	7	183 0.5×	120 0.8×	34 0.6×	29 0.5×	20 0.4×	10	313
Daisuke Morisawa Japan	11	177 0.4×	47 0.3×	88 1.6×	35 0.6×	14 0.3×	25	316

Countries citing papers authored by Nora Aknay

Since Specialization

Citations

This map shows the geographic impact of Nora Aknay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Aknay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Aknay more than expected).

Fields of papers citing papers by Nora Aknay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Aknay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Aknay. The network helps show where Nora Aknay may publish in the future.

Co-authorship network of co-authors of Nora Aknay

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Aknay. A scholar is included among the top collaborators of Nora Aknay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Aknay. Nora Aknay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Majahalme, Silja, Lawrence Baruch, Nora Aknay, et al.. (2005). Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial). The American Journal of Cardiology. 95(4). 529–532. 20 indexed citations

Anand, Inder S., Michael A. Kuskowski, Thomas S. Rector, et al.. (2005). Anemia and Change in Hemoglobin Over Time Related to Mortality and Morbidity in Patients With Chronic Heart Failure. Circulation. 112(8). 1121–1127. 212 indexed citations

Krum, Henry, Peter E. Carson, Csaba Farsang, et al.. (2004). Effect of Valsartan Added to Background ACE Inhibitor Therapy in Patients with Heart Failure: Results from Val-HeFT. European Journal of Heart Failure. 6(7). 937–945. 70 indexed citations

Wong, Maylene, Lidia Staszewsky, Roberto Latini, et al.. (2004). Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure. Journal of the American College of Cardiology. 43(11). 2022–2027. 172 indexed citations

Baruch, Lawrence, Robert Glazer, Nora Aknay, et al.. (2004). Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT). American Heart Journal. 148(6). 951–957. 28 indexed citations

Majahalme, Silja, et al.. (2003). Mortality and morbidity in men, women, and postmenopausal women in Val-HeFT. Journal of the American College of Cardiology. 41(6). 205–205. 1 indexed citations

Anand, Inder S., Robert Glazer, YannTong Chiang, et al.. (2003). A retrospective analysis of major determinants of heart failure mortality in patients receiving both ACE inhibitors and Beta-blockers in Val-HeFT. Journal of Cardiac Failure. 9(5). S83–S83. 1 indexed citations

Tavazzi, Luigi, Ileana L. Piña, YannTong Chiang, et al.. (2002). Association of quality of life with improved clinical outcomes: results from the valsartan heart failure trial. Journal of the American College of Cardiology. 39. 167–167. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact